The patient required revascularization of the target lesion.This is being reported as a follow-up to the clinical registry.Patient information regarding relevant tests/laboratory data is unknown.This information was not available from the facility.Report source: foreign- (b)(6)/ study name: (b)(6): patient id (b)(6).Block g5: pma number is not applicable.The device is a commercial product with a ce mark that was used as part of a clinical registry.Block h3: during the index procedure, the product worked as intended and the device was discarded, thus no product evaluation was performed.Block h6: per the ifu, restenosis is listed as a potential complications/adverse events.H3 other text : placeholder.
|
It was reported through a clinical registry that during the index procedure on (b)(6) 2018, a stellarex catheter was used to treat the target lesion of the left infrapopliteal and proximal peroneal.Approximately 14 months post index procedure, the patient experienced restenosis.A successful revascularization of the target lesion was performed on (b)(6) 2019.
|